STEPHEN STOCKING: Open Payments
NPI 1104903392 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 55 payments from 18 companies in 2025. Trend: 2023 $1,362 · 2024 $1,363 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $249 |
| Lilly USA, LLC | 9 | $151 |
| Sumitomo Pharma America, Inc. | 7 | $130 |
| Dexcom, Inc. | 4 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Astellas Pharma US Inc | 2 | $46 |
| PFIZER INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $38 |
| Corcept Therapeutics | 2 | $36 |
Products named: Ozempic, GEMTESA, MOUNJARO, Dexcom G6 Transmitter, Kerendia, JARDIANCE, AIRSUPRA, Wegovy.
Industry payments across GA — which companies pay providers there.
